搜索临床试验以:basiliximab,
总计126个结果
-
Drexel University College of MedicineNovartis终止
-
Fort Worth Clinical Sciences Working GroupTCU and UNTHSC School of Medicine尚未招聘SARS-CoV2 感染 | 细胞因子风暴 | SARS-CoV-2 急性呼吸道疾病
-
Gary Archer Ph.D.National Cancer Institute (NCI)完全的
-
The First Affiliated Hospital of Soochow UniversityThe Second People's Hospital of Huai'an; Soochow Hopes Hematonosis Hospital招聘中
-
University Health Network, TorontoNovartis完全的
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals完全的
-
Gang ChenChanghai Hospital; First Affiliated Hospital, Sun Yat-Sen University; The First Affiliated Hospital... 和其他合作者完全的
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals完全的
-
University of OxfordNovartis; Pfizer; National Health Service, United Kingdom完全的
-
Coordinación de Investigación en Salud, Mexico完全的
-
Hospital Authority, Hong KongNovartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation未知
-
Indiana University School of Medicine完全的多发性骨髓瘤 | 非霍奇金淋巴瘤 | 骨髓纤维化 | 慢性淋巴细胞白血病 | 贫血,再生障碍性 | 急性淋巴细胞白血病 | 急性髓性白血病 | 慢性粒细胞白血病 | 骨髓增生异常 | 阵发性血红蛋白尿 | 霍奇金病美国
-
Novartis Pharmaceuticals完全的
-
University of KhartoumNational Center for Kidney Diseases and Surgery招聘中
-
University of ChicagoNational Cancer Institute (NCI)完全的伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 缓解期成人急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
Hospital de Clinicas de Porto Alegre未知
-
Cerimon PharmaceuticalsPPD终止
-
Mario Negri Institute for Pharmacological Research终止
-
University Hospital FreiburgRoche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbH完全的
-
First Affiliated Hospital, Sun Yat-Sen UniversitySecond Affiliated Hospital of Guangzhou Medical University未知
-
University of California, Los AngelesNovartis完全的